Metraipolis › archive › dc_a199db7feff6

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer — Europe PMC PMID:41649465

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41649465
DOI: 10.1093/oncolo/oyag032
License (as archived): solo-consultazione
Archived: 2026-11-06T08:57:07.997Z
SHA-256 of the archived text: 67f056de6a2e31a21f6dce9e26922d27a7d9a19aee1b3ed68766b16cfa95c697
Stable URL of this page: https://metraipolis.com/documento/dc_a199db7feff6

How to cite

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer — Europe PMC PMID:41649465 — Europe PMC (en), https://europepmc.org/article/MED/41649465 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a199db7feff6 (Metraipolis archive dc_a199db7feff6, sha256 67f056de6a2e31a21f6dce9e26922d27a7d9a19aee1b3ed68766b16cfa95c697)

BibTeX

@misc{dca199db7feff6,
  title = {Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer — Europe PMC PMID:41649465},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41649465},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a199db7feff6; sha256 67f056de6a2e31a21f6dce9e26922d27a7d9a19aee1b3ed68766b16cfa95c697},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41649465. Agents can read the archived copy with the MCP tool read_document.